Diabetes
News
Despite Cardiac Concerns, FDA OKs Obesity Drug Lorcaserin
News
PSA May Be Unreliable in Type 1 Diabetes
Major Finding: In men with type 1 diabetes, every 10% increase in HbA1c was associated with a 1.3 ng/mL decrease in prostate specific antigen.Data...
News
Metformin May Reduce Liver Cancer Risk
Major Finding: Metformin use reduced the risk of intrahepatic cholangiocarcinoma by nearly 60%, compared with nonmetformin use.
News
Hydroxychloroquine Cuts Diabetes Risk in Rheumatoid Arthritis
News
Chronic Kidney Disease, Diabetes Equivalent MI Predictors
Major Finding: In 4 years of follow-up, the MI rate was 18.5 per 1,000 person-years in patients with a history of MI, 5.4 per 1,000 person-years...
News
When HbA1c Won't Do, Look to Fructosamine Test
Conference Coverage
ORIGIN: Glargine Doesn't Cut Cardiac Events
Conference Coverage
Novel Long-Acting Insulin Causes Less Hypoglycemia
Major Finding: Compared with glargine, there was a 21% lower rate of overall confirmed hypoglycemic episodes with degludec, and a 52% lower rate...
Conference Coverage
Add-On Glargine Bests Sitagliptin for Regaining Glucose Control
Major Finding: Hemoglobin A1c, 8.5% for both groups at baseline, was reduced to a significantly greater extent with insulin glargine than with...
News
Three Glargine Studies Find No Link to Cancer
Major Finding: When comparing glargine to other insulins, the relative risks for breast, colorectal, and prostate cancer never exceeded 1.6, and...
Conference Coverage
SEARCH Turns Up More Diabetes in Youth
Major Finding: From 2001 to 2009, the prevalence of type 1 diabetes rose 23% among American youth aged 20 years and younger.